Kukje Pharma Co., Ltd. (KRX:002720)
4,760.00
-10.00 (-0.21%)
At close: Apr 24, 2026
Kukje Pharma Revenue
In the year 2025, Kukje Pharma had annual revenue of 175.50B KRW with 12.16% growth. Kukje Pharma had revenue of 43.34B in the quarter ending December 31, 2025, with 4.09% growth.
Revenue
175.50B
Revenue Growth
+12.16%
P/S Ratio
0.55
Revenue / Employee
707.65M
Employees
248
Market Cap
96.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 175.50B | 19.03B | 12.16% |
| Dec 31, 2024 | 156.46B | 21.09B | 15.58% |
| Dec 31, 2023 | 135.37B | 8.79B | 6.94% |
| Dec 31, 2022 | 126.58B | 6.84B | 5.71% |
| Dec 31, 2021 | 119.75B | -10.65B | -8.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jeil Pharma Holdings | 657.61B |
| Ildong Holdings | 590.89B |
| HANDOK | 535.14B |
| Dongwha Pharm.Co.,Ltd | 496.39B |
| Kyongbo Pharmaceutical | 264.10B |
| MYUNGMOON Pharm co.,Ltd | 195.25B |
| CKD Bio | 159.93B |
| Yuyu Pharma | 140.88B |